Anthem Biosciences Ltd.

₹938

- 3.70 (-0.39%)

04:01 pm - close price

BSE: ANTHEM

NSE: ANTHEM

Industry: Pharmaceuticals & Drugs

House: Private

Overview

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 10.54Good: 5

✅

Adjusted EPS

Bad: 3Current: 10.54Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 29.62Good: 20

✅

Current Ratio

Bad: 1Current: 3.79Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 21.98Good: 15

✅

Debt to Total Assets

Bad: 1Current: 1.42Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 10.54Good: 5

✅

Adjusted EPS

Bad: 3Current: 10.54Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 29.62Good: 20

✅

Current Ratio

Bad: 1Current: 3.79Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 21.98Good: 15

✅

Debt to Total Assets

Bad: 1Current: 1.42Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.02	14.85	26.44	19.78	47.84	47.84	16.00	2.82	2.31	0.05	45.61	0.61	36.73	29.07	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.31	16.19	32.46	24.43	96.91	96.91	30.00	4.12	2.76	0	142.17	0.54	61.36	51.99	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	11.81	19.69	13.66	9.73	50.10	50.10	1.00	1.27	0.91	0.43	16.09	1.21	17.39	13.62	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	8.03	11.69	17.11	12.34	50.25	50.25	8.00	1.79	1.34	0.20	15.43	0.65	24.97	16.85	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	16.12	27.11	16.95	12.42	116.64	116.64	18.00	1.90	1.42	0.26	16.82	1.30	19.83	15.71	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	7.00	12.69	19.93	12.98	46.34	46.34	1.00	1.07	0.74	0.37	4.62	0.54	43.29	29.32	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	6.64	9.93	7.91	5.04	60.34	60.34	4.00	1.81	1.15	0.20	14.31	1.32	21.60	14.33	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	13.44	18.29	13.43	10.43	192.54	192.54	53.00	2.55	1.86	0.12	18.86	1.29	27.54	23.18	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

Failed to load quarterly results

Profit & Loss

In Rs. Cr.	202203	202303	202403	202503	202603
Sales	12312.55	10569.24	14193.70	18445.53	21243.33
Operational Expenses+	6641.51	6340.53	9142.70	11735.20	12903.60
Operating Profit	5671.04	4228.71	5051.00	6710.33	8339.73
Other Income	489.81	850.44	636.99	857.32	1557.83
OPM %	46.06	40.01	35.59	36.38	39.26
Depreciation and Amortisation	577.56	636.96	818.24	893.71	1340.70
Interest	121.89	87.23	96.57	105.26	70.55
Profit Before Tax	5461.40	4972.98	4773.18	6568.68	8242.40
Tax	1406.01	1121.13	1100.08	2056.08	2324.48
Net Profit	4055.39	3851.85	3673.10	4512.60	5917.92

Balance Sheet

In Rs. Cr.	202203	202303	202403	202503	202603
Assets+	17259.28	21045.49	24767.19	29486.37	36059.69
Liabilities+	17259.28	21045.49	24767.19	29486.37	36059.69

Cash Flow Statement

In Rs. Cr.	202203	202303	202403	202503	202603
Cash from Operating Activity+	3329.13	3059.87	1401.51	2705.50	8444.87
Cash from Investing Activity	-2054.54	-3760.16	-2214.59	-1465.64	-7016.21
Cash from Financing Activity	1806.77	639.73	-771.81	-1356.47	-399.98
Net Cash Flow	3081.36	-60.56	-1584.89	-116.61	1028.68
Opening Cash & Cash Equivalents	407.67	3489.03	3428.47	1843.58	1722.84
Closing Cash & Cash Equivalents	3489.03	3428.47	1843.58	1722.84	2748.81

Shareholder Pattern

In %	JUN'26	MAR'26	DEC'25	SEP'25	JUL'25
Promoters+	71.42	74.68	74.69	74.69	74.69
Public+	28.58	25.32	25.31	25.31	25.31
Custodians	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	173273	180220	199492	217681	825844

Corporate Actions

105 events in the last 3 years

Cash Flow Statement

In Rs. Cr.	202203	202303	202403	202503	202603
Cash from Operating Activity+	3329.13	3059.87	1401.51	2705.50	8444.87
Cash from Investing Activity	-2054.54	-3760.16	-2214.59	-1465.64	-7016.21
Cash from Financing Activity	1806.77	639.73	-771.81	-1356.47	-399.98
Net Cash Flow	3081.36	-60.56	-1584.89	-116.61	1028.68
Opening Cash & Cash Equivalents	407.67	3489.03	3428.47	1843.58	1722.84
Closing Cash & Cash Equivalents	3489.03	3428.47	1843.58	1722.84	2748.81

Balance Sheet

In Rs. Cr.	202203	202303	202403	202503	202603
Assets+	17259.28	21045.49	24767.19	29486.37	36059.69
Liabilities+	17259.28	21045.49	24767.19	29486.37	36059.69

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Shareholder Pattern

In %	JUN'26	MAR'26	DEC'25	SEP'25	JUL'25
Promoters+	71.42	74.68	74.69	74.69	74.69
Public+	28.58	25.32	25.31	25.31	25.31
Custodians	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	173273	180220	199492	217681	825844

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.02	14.85	26.44	19.78	47.84	47.84	16.00	2.82	2.31	0.05	45.61	0.61	36.73	29.07	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.31	16.19	32.46	24.43	96.91	96.91	30.00	4.12	2.76	0	142.17	0.54	61.36	51.99	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	11.81	19.69	13.66	9.73	50.10	50.10	1.00	1.27	0.91	0.43	16.09	1.21	17.39	13.62	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	8.03	11.69	17.11	12.34	50.25	50.25	8.00	1.79	1.34	0.20	15.43	0.65	24.97	16.85	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	16.12	27.11	16.95	12.42	116.64	116.64	18.00	1.90	1.42	0.26	16.82	1.30	19.83	15.71	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	7.00	12.69	19.93	12.98	46.34	46.34	1.00	1.07	0.74	0.37	4.62	0.54	43.29	29.32	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	6.64	9.93	7.91	5.04	60.34	60.34	4.00	1.81	1.15	0.20	14.31	1.32	21.60	14.33	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	13.44	18.29	13.43	10.43	192.54	192.54	53.00	2.55	1.86	0.12	18.86	1.29	27.54	23.18	6.85	26.10	0.64

Scroll horizontally to see more columns

Ratios

Reported EPS

Bad: 2Current: 10.54Good: 5

✅

Adjusted EPS

Bad: 3Current: 10.54Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 29.62Good: 20

✅

Current Ratio

Bad: 1Current: 3.79Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 21.98Good: 15

✅

Debt to Total Assets

Bad: 1Current: 1.42Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 10.54Good: 5

✅

Adjusted EPS

Bad: 3Current: 10.54Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 29.62Good: 20

✅

Current Ratio

Bad: 1Current: 3.79Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 21.98Good: 15

✅

Debt to Total Assets

Bad: 1Current: 1.42Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Quarterly Results

Failed to load quarterly results

Profit & Loss

In Rs. Cr.	202203	202303	202403	202503	202603
Sales	12312.55	10569.24	14193.70	18445.53	21243.33
Operational Expenses+	6641.51	6340.53	9142.70	11735.20	12903.60
Operating Profit	5671.04	4228.71	5051.00	6710.33	8339.73
Other Income	489.81	850.44	636.99	857.32	1557.83
OPM %	46.06	40.01	35.59	36.38	39.26
Depreciation and Amortisation	577.56	636.96	818.24	893.71	1340.70
Interest	121.89	87.23	96.57	105.26	70.55
Profit Before Tax	5461.40	4972.98	4773.18	6568.68	8242.40
Tax	1406.01	1121.13	1100.08	2056.08	2324.48
Net Profit	4055.39	3851.85	3673.10	4512.60	5917.92

Anthem Biosciences Ltd.

₹938

- 3.70 (-0.39%)

04:01 pm - close price

BSE: ANTHEM

NSE: ANTHEM

Industry: Pharmaceuticals & Drugs

House: Private

Overview

Corporate Actions

105 events in the last 3 years